Estrogen inhibits estrogen receptor α-mediated rho-kinase expression in experimental autoimmune encephalomyelitis rats

Synapse

Volumn 67, Issue 7, 2013, Pages 399-406

  Feng, Jinzhou ^a   Zhang, Guanghui ^b   Hu, Xiao ^c   Si Chen, Cindy ^d   Qin, Xinyue ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c GUIZHOU PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Estrogen; Estrogen receptor ; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Rho kinase

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; NEUROFILAMENT PROTEIN; RHO KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WAY 202041;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION; GUINEA PIGS; MALE; NEURONS; RATS; RATS, WISTAR; RHO-ASSOCIATED KINASES;

EID: 84877920172     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21650     Document Type: Article

References (30)

1. Butti E, Bergami A, Recchia A, Brambilla E, Del Carro U, Amadio S, Cattalini A, Esposito M, Stornaiuolo A, Comi G, Pluchino S, Mavilio F, Martino G, Furlan R. 2008. IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis. Gene Ther 15(7):504-515.
2. Chen GQ, Chen YY, Wang XS, Wu SZ, Yang HM, Xu HQ, He JC, Wang XT, Chen JF, Zheng RY. 2010. Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats. Brain Res 1309:116-125.
3. Chrissobolis S, Budzyn K, Marley PD, Sobey CG. 2004. Evidence that estrogen suppresses rho-kinase function in the cerebral circulation in vivo. Stroke 35(9):2200-2205.
4. Giraud SN, Caron CM, Pham-Dinh D, Kitabgi P, Nicot AB. 2010. Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes. Proc Natl Acad Sci USA 107(18):8416-8421.
5. Gold R, Linington C, Lassmann H. 2006. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129(Part 8):1953-1971.
6. Gold SM, Voskuhl RR. 2009. Estrogen and testosterone therapies in multiple sclerosis. Prog Brain Res 175:239-251.
7. Gold SM, Sasidhar MV, Morales LB, Du S, Sicotte NL, Tiwari-Woodruff SK, Voskuhl RR. 2009. Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha). Lab Invest 89(10):1076-1083.
8. Greenwood J, Walters CE, Pryce G, Kanuga N, Beraud E, Baker D, Adamson P. 2003. Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis. FASEB J 17(8):905-907.
9. Gresle MM, Shaw G, Jarrott B, Alexandrou EN, Friedhuber A, Kilpatrick TJ, Butzkueven H. 2008. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis. J Neurosci Res 86(16):3548-3555.
10. Hein Nee Maier K, Kohler A, Diem R, Sattler MB, Demmer I, Lange P, Bahr M, Otto M. 2008. Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis. Neurosci Lett 436(1):72-76.
11. Herrero-Herranz E, Pardo LA, Gold R, Linker RA. 2008. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: Implications for multiple sclerosis. Neurobiol Dis 30(2):162-173.
12. Kubo T, Yamaguchi A, Iwata N, Yamashita T. 2008. The therapeutic effects of Rho-ROCK inhibitors on CNS disorders. Ther Clin Risk Manag 4(3):605-615.
13. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Bruck W. 2002. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125(Part 10):2202-2212.
14. Lassmann H. 2010. Axonal and neuronal pathology in multiple sclerosis: What have we learnt from animal models. Exp Neurol 225(1):2-8.
15. Legge KL, Min B, Bell JJ, Caprio JC, Li L, Gregg RK, Zaghouani H. 2000. Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis. J Exp Med 191(12):2039-2052.
16. Lelu K, Delpy L, Robert V, Foulon E, Laffont S, Pelletier L, Engelhardt B, Guery JC. 2010. Endogenous estrogens, through estrogen receptor alpha, constrain autoimmune inflammation in female mice by limiting CD4(+) T-cell homing into the CNS. Eur J Immunol 40(12):3489-3498.
17. Montague CR, Hunter MG, Gavrilin MA, Phillips GS, Goldschmidt-Clermont PJ, Marsh CB. 2006. Activation of estrogen receptor-alpha reduces aortic smooth muscle differentiation. Circ Res 99(5):477-484.
18. Oviedo PJ, Sobrino A, Laguna-Fernandez A, Novella S, Tarin JJ, Garcia-Perez MA, Sanchis J, Cano A, Hermenegildo C. 2011. Estradiol induces endothelial cell migration and proliferation through estrogen receptor-enhanced RhoA/ROCK pathway. Mol Cell Endocrinol 30;335(2):96-103.
19. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. Academic Press, San Diego, CA.
20. Quintanar JL, Salinas E, Quintanar-Stephano A. 2011. Gonadotropin-releasing hormone reduces the severity of experimental autoimmune encephalomyelitis, a model of multiple sclerosis. Neuropeptides 45(1):43-48.
21. Schmandke A, Strittmatter SM. 2007. ROCK and Rho: Biochemistry and neuronal functions of Rho-associated protein kinases. Neuroscientist 13(5):454-469.
22. Spence RD, Hamby ME, Umeda E, Itoh N, Du S, Wisdom AJ, Cao Y, Bondar G, Lam J, Ao Y, Sandoval F, Suriany S, Sofroniew MV, Voskuhl RR. 2011. Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc Natl Acad Sci USA 108(21):8867-8872.
23. Sun X, Minohara M, Kikuchi H, Ishizu T, Tanaka M, Piao H, Osoegawa M, Ohyagi Y, Shimokawa H, Kira J. 2006. The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis. J Neuroimmunol 180(1-2):126-134.
24. Tao T, Xu G, Si Chen C, Feng J, Kong Y, Qin X. 2013. Minocycline promotes axonal regeneration through suppression of RGMa in rat MCAO/reperfusion model. Synapse 67(4):189-198.
25. Tiwari-Woodruff S, Voskuhl RR. 2009. Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice. J Neurol Sci 286(1-2):81-85.
26. Tiwari-Woodruff S, Morales LB, Lee R, Voskuhl RR. 2007. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc Natl Acad Sci USA 104(37):14813-14818.
27. Uyttenhove C, Sommereyns C, Theate I, Michiels T, Van Snick J. 2007. Anti-IL-17A autovaccination prevents clinical and histological manifestations of experimental autoimmune encephalomyelitis. Ann N Y Acad Sci 1110:330-336.
28. Yang E, Jeon SB, Baek I, Chen ZA, Jin Z, Kim IK. 2009. 17beta-estradiol attenuates vascular contraction through inhibition of RhoA/Rho kinase pathway. Naunyn Schmiedebergs Arch Pharmacol 380(1):35-44.
29. Yates MA, Li Y, Chlebeck PJ, Offner H. 2010. GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol. BMC Immunol 11:20.
30. Yu JZ, Ding J, Ma CG, Sun CH, Sun YF, Lu CZ, Xiao BG. 2010. Therapeutic potential of experimental autoimmune encephalomyelitis by Fasudil, a Rho kinase inhibitor. J Neurosci Res 88(8):1664-1672.